Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
about
Risedronate's efficacy: from randomized clinical trials to real clinical practice.Osteoporosis therapies: evidence from health-care databases and observational population studies.Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007.Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational StudyEfficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.Comorbidities, bone-sparing agent prescription history and their determinants among postmenopausal women in UK primary care settings: a retrospective database study.Fracture incidence in a large cohort of men age 30 years and older with osteoporosis.Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control.Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study.Risk factors for fracture among current, persistent users of bisphosphonates.Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice.Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women.
P2860
Q33965652-278EA7F1-7D2E-4D77-A246-8A7EE385AEA9Q34242906-5B8E78F6-27E8-41BB-95BA-C2D5AE8E49A2Q34440107-76EE2F9F-C4CA-49BD-BDE2-18B473658F2BQ35229889-72E9F135-09A4-4B39-855C-E176E8E0C3BDQ35598005-13E23563-E7D8-4FF3-B8CF-A612F56C2D30Q38702184-A533B6F5-9601-47CB-92AF-1A385CF7E062Q40300226-831C9E3A-8800-4A85-AD7F-AC1C4314E8A5Q41534608-166700B5-9E1F-4F02-8CCE-19FBB052B6BDQ42108489-C2F3E2D1-0492-4B5C-9D5B-E7AB2225FF20Q44381104-705A8A37-D6E9-4099-BA88-D03501F380BFQ44430151-3C88FCA9-006C-4296-B746-0B2522291765Q46244082-6E0555B3-181A-4BD5-A773-F263D016A8F5Q51736759-CBF324BB-4200-4C07-96B1-FF6AE4BAC5C8
P2860
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
@ast
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
@en
type
label
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
@ast
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
@en
prefLabel
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
@ast
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
@en
P2093
P2860
P1476
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-009-1046-3
P407
P577
2009-09-01T00:00:00Z
P5875
P6179
1008954345